May 2 | 2018
2cureX:s VD deltar på Folkemødet 2018 i Danmark
Read more
April 25 | 2018
Kallelse till årsstämma i 2cureX AB (publ)
Read more
April 24 | 2018
2cureX is expanding its operations in Germany with the opening of a screening lab at Centrum für innovative Medizin (CiM), Hamburg
Read more
April 24 | 2018
2cureX utvidgar sin verksamhet genom att öppna ett screeninglab vid Centrum für innovative Medizin (CiM) i Hamburg
Read more
March 13 | 2018
2cureX receives first payment of EUR 1,5 million from EU Horizon 2020
Read more
March 13 | 2018
2cureX har erhållit första utbetalningen om 1,5 MEUR från Horizon 2020
Read more
March 12 | 2018
2cureX inbjudna att presentera IndiTreat® och klinisk data på ESMO i juni 2018
Read more
March 12 | 2018
2cureX invited to present IndiTreat® and clinical data at ESMO in June 2018
Read more
February 27 | 2018
2cureX deltar på Sedermeradagen Köpenhamn
Read more
February 27 | 2018
2cureX will participate at Sedermeradagen Copenhagen
Read more
February 15 | 2018
2cureX offentliggör bokslutskommuniké för verksamhetsåret 2017
Read more
January 22 | 2018
2cureX avtalar om de slutliga villkoren gällande ett bidrag om 29 MSEK från Horizon 2020
Read more
January 22 | 2018
2cureX agrees on final terms concerning an EUR 3 million grant from Horizon 2020
Read more
December 11 | 2017
Large interest in the newly launched clinical trial for 2cureX’s IndiTreat™ test
Read more
December 11 | 2017
Stort intresse för den nyligen inledda kliniska studien med 2cureX:s IndiTreat™-test
Read more
November 29 | 2017
2cureX prepares for market launch of IndiTreat™ in 2020 – international Chief Business Officer is recruited to lead the process
Read more
November 24 | 2017
2cureX AB: Första dag för handel på Nasdaq Stockholm First North
Read more
November 22 | 2017
2cureX AB: Godkänt för notering på Nasdaq Stockholm First North
Read more